NCT02223520View on ClinicalTrials.gov

Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial

NACompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Staph Aureus ColonizationStaph Aureus Infection
Interventions
DRUG

Mupirocin and Chlorhexidine

DRUG

Placebo ointment and placebo cloths

Trial Locations (2)

21224

Johns Hopkins Bayview Medical Center, Baltimore

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Johns Hopkins University

OTHER

NCT02223520 - Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial | Biotech Hunter | Biotech Hunter